ArticleArchives of medical science : AMS2018

Dual therapy based on raltegravir and boosted protease inhibitors - the experience of Polish centers.

Elżbieta Jabłonowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.